Evidence map›Paper›PMID 31281579›Full record

ArticleOxidative medicine and cellular longevity2019

High Levels of

Rebecca Piccarducci, Deborah Pietrobono, Carolina Pellegrini, Simona Daniele, Matteo Fornai, Luca Antonioli, Maria Letizia Trincavelli, Corrado Blandizzi, Claudia Martini

Open access · hybridAbstract read
In one paragraph

Article in Oxidative medicine and cellular longevity, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Rebecca PiccarducciDepartment of Pharmacy, University of Pisa, Pisa, Italy.ORCID 0000-0001-9577-6650
Deborah PietrobonoDepartment of Pharmacy, University of Pisa, Pisa, Italy.ORCID 0000-0002-4986-1472
Carolina PellegriniDepartment of Pharmacy, University of Pisa, Pisa, Italy.ORCID 0000-0003-2644-5430
Simona DanieleDepartment of Pharmacy, University of Pisa, Pisa, Italy.ORCID 0000-0001-7391-3087
Matteo FornaiDepartment of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.ORCID 0000-0002-0812-3959
Luca AntonioliDepartment of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Maria Letizia TrincavelliDepartment of Pharmacy, University of Pisa, Pisa, Italy.ORCID 0000-0001-8124-977X
Corrado BlandizziDepartment of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Claudia MartiniDepartment of Pharmacy, University of Pisa, Pisa, Italy.ORCID 0000-0001-9379-3027
University of Pisa · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Alzheimer's Disease (AD) is the most common Neurodegenerative Disease (ND), primarily characterised by neuroinflammation, neuronal plaques of

Indexed as

Alzheimer DiseaseAmyloid beta-PeptidesAnimalsBiomarkersDisease Models, AnimalErythrocytesMiceMice, Transgenictau ProteinsAmyloid beta-PeptidesBiomarkerstau Proteins

Identifiers

PMID31281579
PMCPMC6590616
OpenAlexW2948844134

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.